On 02.07.24 Polish scientific journal “Futurity Medicine” published a scientific article “The Neuropathy As an Adverse Effect of Chemotherapy Diminished After Administration of Dietary Supplement with Iron Citrate”. The case study outlined how Synthesit has helped a 51-year old woman undergoing chemotherapy. Her blood indicators and inflammation markers were monitored.
This research examined how adding Synthesit affected chemotherapy-induced nerve damage in a patient diagnosed with primary fallopian tube cancer.
The case study showed how Synthesit influences immune function and hematologic parameters during chemotherapy. This study distinctively investigated the influence of iron citrate on changes in hematologic and immune parameters during chemotherapy.
Overall conclusion has been that Synthesit may affect the blood counts, red blood cell production, and immune markers, aiding in chemotherapy-induced neuropathy management.
Please read the full scientific paper here:
